The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Blog
Tuesday 10 February 2015
Following on from my recent Cancer Drugs Fund (CDF) blog I thought it would be helpful to delve into the byzantine processes for accessing drugs across all the devolved nations of the UK. Now, as I hope we all know by now National Institute for Health and Care Excellence (NICE) is responsible for...
Blog
Monday 19 January 2015
Last week, the Cancer Drugs Fund (CDF) announced the results of its recent review of over 50 cancer drugs, including four ovarian cancer drugs. Our Head of Research, Dr Simon Newman, explains what the decisions mean. Read Annie Mulholland's blog for a patient's perspective Well now the dust has...
Blog
Monday 19 January 2015
Last week, the Cancer Drugs Fund (CDF) announced the results of its recent review of over 50 cancer drugs, including four ovarian cancer drugs. Annie Mulholland has received treatment with Avastin, and tells us about the implications of the review, from her perspective. Read Dr Simon Newman's blog...
News
Tuesday 13 January 2015
The Scottish Medicines Consortium (SMC) has announced the results of its recent review of cancer drugs and was unable to accept bevacizumab (Avastin) for first line treatment of advanced stage ovarian cancer (stage 3C/4). Despite patient groups and clinicians highlighting the potential benefits of...

Pages